MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MNKD — Mannkind Corporation
NasdaqMannkind Corporation
$3.71
-0.11(-2.88%)
- O
- 3.86
- H
- 3.86
- L
- 3.69
- V
- 3.05M
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MNKD
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 28, 2004
Employees592
Stock ExchangeNasdaq
Ticker SymbolMNKD
Websitehttps://www.mannkindcorp.com
Key Financial Statistics
| Market Cap | $1.22B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.23 - $6.51 |
| 52-Week Avg Volume | 4.94M |
| VWAP | $3.74 |
| Transactions | 11,891 |
| Total Recorded Bars | 5,583 days |